Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Corruption Probed At China’s FDA

by Jean-François Tremblay
June 21, 2010 | A version of this story appeared in Volume 88, Issue 25

A senior official at China’s State Food & Drug Administration has been suspended from his duties for suspected corruption. China’s state media reported that Zhang Jingli, one of the agency’s four deputy commissioners, is under investigation for “disciplinary violations,” a phrase that usually means accepting bribes. Several senior SFDA officials have been involved in corruption cases in recent years. In 2007, Zheng Xiaoyu, the director of the agency, was executed for approving unsafe drugs in exchange for kickbacks (C&EN, July 16, 2007, page 9). In April of this year, state media reported that five drug safety officials, mostly responsible for vaccines, had been arrested for taking bribes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.